Dirk HOUWERS | Director | DVM, PhD | R&D | Research profile
Dirk HOUWERS | Director | DVM, PhD | R&D | Research profile
INFORMATION TO USERS
Anti-hIL-6R antibodies | Tocilizumab biosimilar isotypes | InvivoGen
M. hyo Ab Test: Mycoplasma hyopneumoniae (M. hyo) - IDEXX US
UvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository)
Anti-IL-6 neutralizing monoclonal antibody | InvivoGen
IgG1, Kappa from murine myeloma clone MOPC 21, purified immunoglobulin, buffered aqueous solution Mouse IgG1-kappa
IgG1, Kappa from murine myeloma clone MOPC 21, purified immunoglobulin, buffered aqueous solution Mouse IgG1-kappa
Anti Mouse Kappa Light Chain Antibody, clone OX-20 | Bio-Rad
In vivo Grade Mouse IgG2a kappa Isotype Control - CrownVivo™ Antibody -
Dirk HOUWERS | Director | DVM, PhD | R&D | Research profile
SARS-CoV-2 RBD mAb | LY-CoV-derived | InvivoGen
In vivo Grade Mouse IgG2a kappa Isotype Control - CrownVivo™ Antibody - MBL International
HA Tag antibody (66006-2-Ig) | Proteintech
Anti-Hu Ig Kappa Light Chain APC - EXBIO Antibodies
UvA-DARE (Digital Academic Repository)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)
Recombinant Human CD16a/FCGR3A/Fc gamma RIIIA Protein, HEK293 Cells, His Tag, 10389-H08H1 | Sino Biological
CaptureSelect™ KappaXL PhyTip columns for purification of human IgGs
Human Ig Kappa Light Chain Antibody MAB10050-100: R&D Systems
Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome
Dirk HOUWERS | Director | DVM, PhD | R&D | Research profile
Dirk HOUWERS | Director | DVM, PhD | R&D | Research profile
